AcelRx Pharmaceuticals
Latest round
- Series C
Last raised
- Nov 2009
Total raised
- Undisclosed
Investors
- 5
About AcelRx Pharmaceuticals
AcelRx Pharmaceuticals, Inc.Founded in 2005, AcelRx Pharmaceuticals, Inc. is headquartered in Redwood City, US. The company specializes in developing therapies for patients who require anticoagulation during renal replacement therapy. Pamela Palmer is the founder.AcelRx Pharmaceuticals is known for its core product, Niyad™ (nafamostat mesylate), designed as the first FDA-approved regional anticoagulant for extracorporeal circuits during renal replacement therapy. Additionally, the company collaborates with Laboratoire Aguettant to create prefilled syringe products like Fedsyra™ (ephedrine) and PFS-02 (phenylephrine), aimed at enhancing the administration of antihypotensive medications in acute care settings.In the most recent fiscal year 2023, AcelRx Pharmaceuticals reported revenue of USD 651,000. The company's EBITDA for 2024 was recorded at USD -15,131,000. The company is focused on launching new therapeutic solutions, expanding its product line, and entering additional markets in the US and Asia by 2024. AcelRx aims to address the increasing demand for effective anticoagulation therapies in medically supervised environments.
Who invested in AcelRx Pharmaceuticals
5 investors across 1 round
See all investors in AcelRx Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Nov 13, 2009
Amount
Undisclosed
Investors
Questions about AcelRx Pharmaceuticals
Who invested in AcelRx Pharmaceuticals?
AcelRx Pharmaceuticals has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has AcelRx Pharmaceuticals raised?
AcelRx Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did AcelRx Pharmaceuticals last raise money?
AcelRx Pharmaceuticals's most recent round on record is a Series C, in Nov 2009.
What does AcelRx Pharmaceuticals do?
AcelRx Pharmaceuticals is a pharmaceuticals company.
Where is AcelRx Pharmaceuticals headquartered?
AcelRx Pharmaceuticals is headquartered in Redwood City, US.
Which VCs invest in companies like AcelRx Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at AcelRx Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like AcelRx Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.